
Dan Brecher
Counsel
212-286-0747 dbrecher@sh-law.comFirm Insights
Author: Dan Brecher
Date: February 19, 2014
Counsel
212-286-0747 dbrecher@sh-law.comWhile the Securities and Exchange Commission (SEC) may have a spotty record when it comes to insider trading cases, U.S. Attorney Preet Bharara has an impressive winning streak. He is 79-0 in securing insider-trading convictions over the past four years.
Former hedge fund trader Mathew Martoma is the latest guilty verdict for Bharara, whose other high-profile victories include Galleon Group founder Raj Rajaratnam and former Goldman Sachs director and McKinsey managing director Rajat Gupta.
In the latest case, Martoma was charged with orchestrating a scheme to trade on inside information about Alzheimer drug trials conducted by Elan Corporation and Wyeth Pharmaceuticals, which ultimately led to billion dollars in profits for his employer, SAC capital, and $9 million in bonuses for himself. According to prosecutors, the $276 million insider-trading scheme is the largest to date.
“In the short run, cheating may have been profitable for Martoma, but in the end, it made him a convicted felon, and likely will result in the forfeiture of his illegal windfall and the loss of his liberty,” Bharara said in a statement. Martoma now faces more than ten years in prison after being found guilty of two counts of securities fraud and one count of conspiracy to commit securities fraud.
As previously reported on our Business Law News Blog, SAC Capital already agreed to pay nearly $1.8 billion in penalties to resolve allegations of insider trading. The civil case against SAC’s founder, Steven Cohen, who was once one of the world’s most powerful and successful players in the hedge fund industry, is still ongoing.
While Cohen does not yet face criminal charges, the investigation is still ongoing. At trial, the government’s star witness, Dr. Sidney Gilman, testified that a federal agent told him that he and Martoma were only grains of sand and that prosecutors were “really after a man named Steven A. Cohen.” As the statute of limitations draws near, Bharara will have to decide whether to put his winning record to the ultimate test.
Either way, the message for the rest of the financial industry is clear. Given the intense scrutiny on insider trading by both state and federal authorities, firms should ensure that they have comprehensive policies and procedures in place to monitor trading compliance.
If you have any questions about the latest insider trading conviction or need assistance bolstering your firm’s compliance practices, please contact me, Dan Brecher, or the Scarinci Hollenbeck attorney with whom you work.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Author: Jesse M. Dimitro
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
Author: Scarinci Hollenbeck, LLC
Big changes sometimes occur during the life cycle of a contract. Cancelling a contract outright can be bad for your reputation and your bottom line. Businesses need to know how to best address a change in circumstances, while also protecting their legal rights. One option is to transfer the “benefits and the burdens” of a […]
Author: Dan Brecher
What is a trade secret and why you you protect them? Technology has made trade secret theft even easier and more prevalent. In fact, businesses lose billions of dollars every year due to trade secret theft committed by employees, competitors, and even foreign governments. But what is a trade secret? And how do you protect […]
Author: Ronald S. Bienstock
If you are considering the purchase of a property, you may wonder — what is title insurance, do I need it, and why do I need it? Even seasoned property owners may question if the added expense and extra paperwork is really necessary, especially considering that people and entities insured by title insurance make fewer […]
Author: Patrick T. Conlon
If you operate a business, you need to understand how commercial zoning rules may impact you. For instance, zoning regulations can determine how you can develop a property and what type of activities your business can conduct. To ensure that you aren’t taken by surprise, it is always a good idea to consult with experienced […]
Author: Jesse M. Dimitro
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
While the Securities and Exchange Commission (SEC) may have a spotty record when it comes to insider trading cases, U.S. Attorney Preet Bharara has an impressive winning streak. He is 79-0 in securing insider-trading convictions over the past four years.
Former hedge fund trader Mathew Martoma is the latest guilty verdict for Bharara, whose other high-profile victories include Galleon Group founder Raj Rajaratnam and former Goldman Sachs director and McKinsey managing director Rajat Gupta.
In the latest case, Martoma was charged with orchestrating a scheme to trade on inside information about Alzheimer drug trials conducted by Elan Corporation and Wyeth Pharmaceuticals, which ultimately led to billion dollars in profits for his employer, SAC capital, and $9 million in bonuses for himself. According to prosecutors, the $276 million insider-trading scheme is the largest to date.
“In the short run, cheating may have been profitable for Martoma, but in the end, it made him a convicted felon, and likely will result in the forfeiture of his illegal windfall and the loss of his liberty,” Bharara said in a statement. Martoma now faces more than ten years in prison after being found guilty of two counts of securities fraud and one count of conspiracy to commit securities fraud.
As previously reported on our Business Law News Blog, SAC Capital already agreed to pay nearly $1.8 billion in penalties to resolve allegations of insider trading. The civil case against SAC’s founder, Steven Cohen, who was once one of the world’s most powerful and successful players in the hedge fund industry, is still ongoing.
While Cohen does not yet face criminal charges, the investigation is still ongoing. At trial, the government’s star witness, Dr. Sidney Gilman, testified that a federal agent told him that he and Martoma were only grains of sand and that prosecutors were “really after a man named Steven A. Cohen.” As the statute of limitations draws near, Bharara will have to decide whether to put his winning record to the ultimate test.
Either way, the message for the rest of the financial industry is clear. Given the intense scrutiny on insider trading by both state and federal authorities, firms should ensure that they have comprehensive policies and procedures in place to monitor trading compliance.
If you have any questions about the latest insider trading conviction or need assistance bolstering your firm’s compliance practices, please contact me, Dan Brecher, or the Scarinci Hollenbeck attorney with whom you work.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!